Amyotrophic lateral sclerosis
Takeda licenses AcuraStemās antisense drug for ALS targeting PIKFYVE
Anika Sharma
As scientific research continues to underscore the potential of targeting the PIKFYVE enzyme in the quest to combat amyotrophic lateral ...
Amylyx Pharmaceuticals Shines with ALS Drug’s Relyvrio’s Strong Performance and Promising Path Forward
SG Tylor
Amylyx Pharmaceuticals continues to impress the financial world with its amyotrophic lateral sclerosis (ALS) drug, Relyvrio. The medication, known by ...
Regulatory Update: Amylyx’s ALS drug faces rejection by the European Medicines Agency (EMA)
SG Tylor
Source – Amylyx Pharmaceuticals On June 23, 2023, the European Medicines Agency (EMA) has formally issued a negative opinion regarding ...
